This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Colonaryconcepts LLC. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: David Humphries: Innovator in PEG Metabolite Assays
Introduction
David Humphries is a notable inventor based in Mattawan, MI (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods for analyzing polyethylene glycol (PEG) metabolites. With a total of 2 patents, his work has implications for various applications in medical and environmental research.
Latest Patents
David Humphries' latest patents focus on "Compounds and methods for PEG metabolite and PEG breakdown product assays." These patents disclose innovative compounds and methods for identifying and quantifying metabolites or breakdown products of PEG. The assays utilize liquid chromatography combined with mass spectrometry to analyze samples for PEG metabolites or breakdown products. The process involves the derivatization of PEG metabolites or breakdown products within the sample using pentafluorobenzoyl chloride, optimizing the assay through negative chemical ionization mode liquid chromatography.
Career Highlights
Throughout his career, David has demonstrated a commitment to advancing scientific knowledge and practical applications in his field. His work has been instrumental in enhancing the accuracy and efficiency of assays related to PEG, which is widely used in pharmaceuticals and other industries.
Collaborations
David collaborates with talented individuals such as Kevin Douglass and Beauregard Mason. Their combined expertise contributes to the innovative research and development efforts at Colonary Concepts LLC, where David is currently employed.
Conclusion
David Humphries stands out as an inventor dedicated to improving methods for analyzing PEG metabolites. His contributions to the field are significant and continue to influence research and applications in biochemistry.